Assessment of Thiopurine–based drugs according to Thiopurine S-methyltransferase genotype in patients with Acute Lymphoblastic Leukemia
For the past half century, thiopurines have earned themselves a reputation as effective anti-cancer and immunosuppressive drugs.
Main Authors: | Azimi, F, Jafariyan, M, Khatami, S, Mortazavi, Y, Azad, M |
---|---|
Format: | Online |
Language: | English |
Published: |
Shahid Sadoughi University of Medical Sciences
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980020/ |
Similar Items
-
Thiopurine methyltransferase polymorphisms in children with acute lymphoblastic leukemia
by: Linga, Vijay Gandhi, et al.
Published: (2014) -
Thiopurine methyltransferase genotyping in Palestinian childhood acute lymphoblastic leukemia patients
by: Ayesh, Basim Mohammad, et al.
Published: (2013) -
Thiopurine methyltransferase (TPMT) genotyping to predict myelosuppression risk
by: Nguyen, Christine M., et al.
Published: (2011) -
Thiopurine methyltransferase genotype and thiopurine S-methyltransferase activity in Greek children with inflammatory bowel disease
by: Gazouli, Μaria, et al.
Published: (2012) -
Thiopurine S-Methyltransferase and Methylenetetrahydrofolate Reductase Polymorphisms in Leukemia
by: KÜPELİ, Serhan
Published: (2015)